Arca

FDA this week

Nov 9 to Nov 15, 2026

What FDA published for drug, device and biologics teams: 3 warning letters, 5 OAI inspections, 24 recalls, 1 promotion letter, 1 new guidance, 4 Federal Register documents, 72 drug shortage updates.

Warning letters 3

Search every warning letter

Inspections classified Official Action Indicated 5

Search inspection outcomes

Recalls 24

Search every drug and device recall

Abiomed, Inc.Class I

Automated Impella Controller, Packaged. Primary user control interface for the Impella Catheter, catheter-based heart pump. (and 2 more products)

Class I · Device · Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to…

Full record

ABC Compounding Co., Inc.

Wechem Hand Guard8/1000mL Bag, Manufactured by: ABC Compounding Co., Inc., 2600 Dogwood Dr., Conyers, GA, 30013 (and 18 more products)

Class II · Drug · CGMP Deviations

Full record

ARJOHUNTLEIGH POLSKA Sp. z.o.o.

Carevo, Height-adjustable shower trolley, Model Number BAC1111-01

Class II · Device · The side support of the shower trolley may open unintentionally when the handles are not fully locked and additional force is applied during patient handling. If the side support is not fully locked…

Full record

BioMerieux SA

EMAG system Model/Catalog Number: 418591/418591U Product Description: Nucleic acid sample preparation instrument IVD, automated

Class II · Device · Delayed or no result when analyzing clinical samples with EMAG system (ref: 418591/418591U) due to a randomly occurring software error, Error 10003 Heater timeout after updating to recent firmware SP4…

Full record

Boston Scientific Neuromodulation Corporation

Nalu TD2 Therapy Disc with firmware, REF: 34014-001, and TD2 Patient Kit, REF: 74011, part of the Nalu Neurostimulation System

Class II · Device · Therapy Disc (TD) that powers and sends stimulation signals to an Implantable Pulse Generator (IPG), part of a neurostimulation system, has a firmware issue that causes the TD to attempt to restart…

Full record

Brandywine Pharmaceuticals, LLC

Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA… (and 1 more product)

Class II · Drug · CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory

Full record

Canon Medical System, USA, INC.

ALPHENIX INTERVENTIONAL ANGIOGRAPHY SYSTEM REF: INFX-8000F (and 2 more products)

Class II · Device · Due to software issue, X-ray interventional system may experience internal error if F-Store or imagine acquisition is performed while clinical analysis function is use.

Full record

Direct Rx

Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50

Class II · Drug · Subpotent Drug

Full record

Eagle Pharma Outsourcing LLC

PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA… (and 1 more product)

Class II · Drug · Lack of Assurance of Sterility

Full record

Ethicon, LLC

ETHILON Nylon Suture, Product Code 697G

Class II · Device · Nylon suture indicated for use in general soft tissue approximation and/or ligation may have needles with distorted curvature, that may break during use, or could cause additional soft tissue or…

Full record

Glenmark Pharmaceuticals Inc., USA

Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC…

Class II · Drug · Labeling: Not Elsewhere Classified

Full record

Huons Co., Ltd.

Carboxymethylcellulose Sodium, 0.5% Lubricant Eye Drops, Sterile, 30 Single-Use Containers, 0.02 FL OZ (0.5 mL) each, Manufactured by: Huons…

Class II · Drug · Failed Impurities/Degradation Specification; detection of polyethylene (PE)-related oligomers

Full record

MACLEODS PHARMA USA, INC

Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b)…

Class II · Drug · Failed Dissolution Specifications.

Full record

Medtronic, Inc.

OmniaSecure Model 3930M, LEAD 3930M74 74 CM DF4 MR 3930M74 LEAD 3930M79 79 CM DF4 MR 3930M79 The Medtronic OmniaSecure" Model 3930M lead is…

Class II · Device · Affected leads require additional engineering evaluation due to complaints regarding difficulty in achieving fixation during implantation. Potential harm of tissue trauma due to implant difficulty.

Full record

Medtronic, Inc.

CareLink SmartSync Programmer, Model 24970A, Pulse generator, permanent, implantable (and 2 more products)

Class II · Device · Software problem has the potential for an inaccurate displayed longevity estimate.

Full record

Pentax of America Inc

PENTAX Medical Ultrasound Endoscope. Model Numbers. EG-3870UTK, EG-3670URK. (and 4 more products)

Class II · Device · Warnings added to the IFU for ultrasound endoscopes and water bottle assembly to ensure there is deaerated sterile water in the assembly prior to and during the procedure.

Full record

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.

Philips Azurion 5 M12. Model Number: 722227. (and 8 more products)

Class II · Device · Solid-State Drives (SSDs) that are not specified in the Medical Device File may have been installed in various PCs. These SSDs may have different performance characteristics, which may include reduced…

Full record

Philips North America

Model Number: 712010.

Class II · Device · Potential for the device to fail immediately after an exposure, causing the system to remain stationary.

Full record

Safecor Health, LLC

Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC…

Class II · Drug · Manufacturer is recalling batches due to co-mingled tablet.

Full record

Stryker Leibinger GmbH & Co. KG

Precision Pointer Electromagnetic (8000-050-001)

Class II · Device · Device may fracture during use at the laser welded joint on the pointer tube. If this happens, loose parts may fall out of the product while the device is inside the patient.

Full record

The Ritedose Corporation

Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60…

Class II · Drug · Failed Impurities/Degradation Specification

Full record

ZIEHM-ORTHOSCAN INC

Orthoscan VERSA Accessory Cart, REF: 1000-0021 and Versa Mini C-Arm System, REF: 1000-0020

Class II · Device · The accessory cart weldment does not conform to weld dimensional specifications which may result in separation of the monitor arm mounting structure from the cart.

Full record

Promotion letters: FDA letters about drug and biologic advertising 1

Search every OPDP letter

New guidance documents 1

Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency: Guidance for Industry and Food and Drug Administration Staff

Final · CDRH

Read at FDA

Federal Register: rules, proposed rules and notices 4

Hematology and Pathology Devices; Reclassification of Immunohistochemistry Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product

Proposed rule · comments close 2027-01-11

Read in the Federal Register

Patient-Level Data for Drugs and Biological Products Submissions Containing Real-World Data and Real-World Evidence; Request for Information

Notice · comments close 2027-01-11

Read in the Federal Register

Early-Phase IND Protocol Recommendations for Solid Tumors; Draft Guidance for Industry; Availability

Notice · comments close 2027-01-11

Read in the Federal Register

Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency; Guidance for Industry and Food and Drug Administration Staff; Availability

Notice

Read in the Federal Register

Current drug shortages updated this week 72

B. Braun Medical Inc.

Heparin Sodium Injection · Injection · Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10) (+1 related packages)

Current · Revised · updated 2026-11-10 · NDC 0264-9872-10 · reason: Other · availability: Limited Availability · 2 related packages grouped

Check current status at FDA

Piramal Critical Care Inc.

Morphine Sulfate Injection · Injection · Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02) (+1 related packages)

Current · Revised · updated 2026-11-10 · NDC 66794-160-02 · reason: Demand increase for the drug · availability: Limited Availability · 2 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Dopamine Hydrochloride Injection · Injection · Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) (+2 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-5820-01 · reason: Other · availability: Unavailable · 3 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection · Injection · Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01) (+5 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-3182-01 · reason: Other · availability: Unavailable · 6 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Carboplatin Injection · Injection · Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05) (+3 related packages)

Current · Revised · updated 2026-11-09 · NDC 61703-150-05 · reason: Other · availability: Unavailable · 4 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Carboplatin Injection · Injection · Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18)

Current · Revised · updated 2026-11-09 · NDC 61703-339-18 · reason: Demand increase for the drug · availability: Limited Availability

Check current status at FDA

Hospira, Inc., a Pfizer Company

Lidocaine Hydrochloride Injection · Injection · Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01) (+1 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-4275-01 · reason: Other · availability: Unavailable · 2 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection · Injection · Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL…

Current · Revised · updated 2026-11-09 · NDC 0409-1752-50 · reason: Other · availability: Limited Availability

Check current status at FDA

Hospira, Inc., a Pfizer Company

Furosemide Injection · Injection · Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26) (+2 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-6102-26 · reason: Other · availability: Unavailable · 3 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection · Injection · Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01) (+3 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-3181-01 · reason: Other · availability: Limited Availability · 4 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection · Injection · Bupivacaine Hydrochloride with Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01) (+5 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-9045-01 · reason: Other · availability: Unavailable · 6 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Hydromorphone Hydrochloride Injection · Injection · Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01) (+1 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-1805-01 · reason: Other · availability: Unavailable · 2 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Ketorolac Tromethamine Injection · Injection · Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) (+2 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-3795-01 · reason: Other · availability: Unavailable · 3 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Methotrexate Sodium Injection · Injection · Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) Multiple Dose Vial PREMIERProRx (NDC 61703-161-05)

Current · Revised · updated 2026-11-09 · NDC 61703-161-05 · reason: Other · availability: Unavailable

Check current status at FDA

Hospira, Inc., a Pfizer Company

Midazolam Hydrochloride Injection · Injection · Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) (+2 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-2308-02 · reason: Demand increase for the drug · availability: Unavailable · 3 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Lorazepam Injection · Injection · Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)

Current · Revised · updated 2026-11-09 · NDC 0409-1985-30 · reason: Demand increase for the drug · availability: Limited Availability

Check current status at FDA

Hospira, Inc., a Pfizer Company

Morphine Sulfate Injection · Injection · Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-2022-01) (+1 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-2022-01 · reason: Other · availability: Unavailable · 2 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Carboplatin Injection · Injection · Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22) (+2 related packages)

Current · Revised · updated 2026-11-09 · NDC 61703-339-22 · reason: Other · availability: Limited Availability · 3 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Midazolam Hydrochloride Injection · Injection · Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2305-50)

Current · Revised · updated 2026-11-09 · NDC 0409-2305-50 · reason: Other · availability: Unavailable

Check current status at FDA

Hospira, Inc., a Pfizer Company

Midazolam Hydrochloride Injection · Injection · Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) (+2 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-2305-05 · reason: Demand increase for the drug · availability: Limited Availability · 3 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Sodium Bicarbonate Injection · Injection · Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)

Current · Revised · updated 2026-11-09 · NDC 0409-5555-02 · reason: Demand increase for the drug · availability: Limited Availability

Check current status at FDA

Hospira, Inc., a Pfizer Company

Fentanyl Citrate Injection · Injection · Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) (+1 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-9094-25 · reason: Demand increase for the drug · availability: Limited Availability · 2 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Bupivacaine Hydrochloride Injection · Injection · Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) (+1 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-1160-01 · availability: Available · 2 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Hydromorphone Hydrochloride Injection · Injection · Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36) (+1 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-1312-36 · reason: Other · availability: Limited Availability · 2 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Dextrose Monohydrate 50% Injection · Injection · Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02)

Current · Revised · updated 2026-11-09 · NDC 0409-6648-02 · reason: Other · availability: Limited Availability

Check current status at FDA

Hospira, Inc., a Pfizer Company

Lidocaine Hydrochloride Injection · Injection · Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05)

Current · Revised · updated 2026-11-09 · NDC 0409-1323-05 · availability: Available

Check current status at FDA

Hospira, Inc., a Pfizer Company

Sodium Bicarbonate Injection · Injection · Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01)

Current · Revised · updated 2026-11-09 · NDC 0409-5555-01 · reason: Other · availability: Limited Availability

Check current status at FDA

Hospira, Inc., a Pfizer Company

Hydromorphone Hydrochloride Injection · Injection · Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)

Current · Revised · updated 2026-11-09 · NDC 0409-1283-31 · reason: Demand increase for the drug · availability: Limited Availability

Check current status at FDA

Hospira, Inc., a Pfizer Company

Dobutamine Hydrochloride Injection · Injection · Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)

Current · Revised · updated 2026-11-09 · NDC 0409-2344-88 · reason: Other · availability: Unavailable

Check current status at FDA

Hospira, Inc., a Pfizer Company

Morphine Sulfate Injection · Injection · Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23) (+1 related packages)

Current · Revised · updated 2026-11-09 · NDC 0409-1890-23 · reason: Other · availability: Limited Availability · 2 related packages grouped

Check current status at FDA

Hospira, Inc., a Pfizer Company

Morphine Sulfate Injection · Injection · Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01)

Current · Reverified · updated 2026-11-09 · NDC 0409-1893-01 · reason: Discontinuation of the manufacture of the drug · availability: Unavailable

Check current status at FDA

Hospira, Inc., a Pfizer Company

Bupivacaine Hydrochloride Injection · Injection · Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10)

Current · Revised · updated 2026-11-09 · NDC 0409-1761-10 · reason: Other · availability: Unavailable

Check current status at FDA

Sandoz Inc.

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · Tablet · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate… (+3 related packages)

Current · Revised · updated 2026-11-09 · NDC 0185-0842-01 · reason: Other · availability: Limited Availability · 4 related packages grouped

Check current status at FDA

Amphastar Pharmaceuticals, Inc.

Sodium Bicarbonate Injection · Injection · Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)

Current · Reverified · updated 2026-11-06 · NDC 76329-3352-1 · reason: Demand increase for the drug · availability: Limited Availability

Check current status at FDA

Amphastar Pharmaceuticals, Inc.

Dextrose Monohydrate 50% Injection · Injection · Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1)

Current · Reverified · updated 2026-11-06 · NDC 76329-3302-1 · reason: Demand increase for the drug · availability: Limited Availability

Check current status at FDA

Pfizer Inc.

Penicillin G Benzathine Injection · Injection · Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10) (+1 related packages)

Current · Revised · updated 2026-11-06 · NDC 60793-701-10 · reason: Other · availability: Limited Availability · 2 related packages grouped

Check current status at FDA

Pfizer Inc.

Clindamycin Phosphate Injection · Injection · Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18) (+2 related packages)

Current · Revised · updated 2026-11-06 · NDC 0009-0902-18 · reason: Other · availability: Unavailable · 3 related packages grouped

Check current status at FDA

Pfizer Inc.

Penicillin G Benzathine Injection · Injection · Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10)

Current · Revised · updated 2026-11-06 · NDC 60793-700-10 · reason: Other · availability: Unavailable

Check current status at FDA

Pfizer Inc.

Dexmedetomidine Hydrochloride Injection · Injection · Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10)

Current · Revised · updated 2026-11-06 · NDC 0409-3301-10 · availability: Available

Check current status at FDA

Sagent Pharmaceuticals

Clindamycin Phosphate Injection · Injection · Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06) (+1 related packages)

Current · Reverified · updated 2026-11-06 · NDC 25021-115-06 · reason: Discontinuation of the manufacture of the drug · availability: Limited Availability · 2 related packages grouped

Check current status at FDA

Sagent Pharmaceuticals

Methylprednisolone Acetate Injection · Injection · Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05)

Current · Revised · updated 2026-11-06 · NDC 25021-821-05 · reason: Shortage of an active ingredient · availability: Unavailable

Check current status at FDA

Sagent Pharmaceuticals

Methylprednisolone Acetate Injection · Injection · Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10)

Current · Revised · updated 2026-11-06 · NDC 25021-820-10 · reason: Shortage of an active ingredient · availability: Limited Availability

Check current status at FDA

Sagent Pharmaceuticals

Ketorolac Tromethamine Injection · Injection · Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)

Current · Revised · updated 2026-11-06 · NDC 25021-701-02 · reason: Demand increase for the drug · availability: Unavailable

Check current status at FDA

Sagent Pharmaceuticals

Ketorolac Tromethamine Injection · Injection · Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)

Current · Revised · updated 2026-11-06 · NDC 25021-700-01 · reason: Delay in shipping of the drug · availability: Limited Availability

Check current status at FDA

Sagent Pharmaceuticals

Clindamycin Phosphate Injection · Injection · Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)

Current · Reverified · updated 2026-11-06 · NDC 25021-115-04 · reason: Discontinuation of the manufacture of the drug · availability: Unavailable

Check current status at FDA

Sanofi-Aventis U.S. LLC

Rifampin Injection · Injection · Rifadin, Injection, 600 mg (NDC 0068-0597-01)

Current · Revised · updated 2026-11-06 · NDC 0068-0597-01 · reason: Discontinuation of the manufacture of the drug · availability: Unavailable

Check current status at FDA

Baxter Healthcare

Clindamycin Phosphate Injection · Injection · Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)

Current · Revised · updated 2026-11-03 · NDC 0338-9549-50 · reason: Other · availability: Limited Availability

Check current status at FDA

Baxter Healthcare

Clindamycin Phosphate Injection · Injection · Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)

Current · Revised · updated 2026-11-03 · NDC 0338-3814-50 · reason: Other · availability: Unavailable

Check current status at FDA

Baxter Healthcare

Dopamine Hydrochloride Injection · Injection · Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)

Current · Revised · updated 2026-11-03 · NDC 0338-1007-03 · reason: Demand increase for the drug · availability: Limited Availability

Check current status at FDA

Fresenius Kabi USA, LLC

Ropivacaine Hydrochloride Injection · Injection · Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)

Current · Reverified · updated 2026-11-03 · NDC 63323-288-20 · reason: Delay in shipping of the drug · availability: Unavailable

Check current status at FDA

Fresenius Kabi USA, LLC

Ropivacaine Hydrochloride Injection · Injection · Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)

Current · Reverified · updated 2026-11-03 · NDC 63323-285-13 · reason: Other · availability: Unavailable

Check current status at FDA

Fresenius Kabi USA, LLC

Bupivacaine Hydrochloride Injection · Injection · Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31)

Current · Reverified · updated 2026-11-03 · NDC 63323-464-31 · reason: Demand increase for the drug · availability: Unavailable

Check current status at FDA

Fresenius Kabi USA, LLC

Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection · Injection · Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37)

Current · Revised · updated 2026-11-03 · NDC 63323-462-37 · reason: Other · availability: Unavailable

Check current status at FDA

Fresenius Kabi USA, LLC

Furosemide Injection · Injection · Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04)

Current · Revised · updated 2026-11-03 · NDC 63323-280-04 · reason: Delay in shipping of the drug · availability: Unavailable

Check current status at FDA

Fresenius Kabi USA, LLC

Lidocaine Hydrochloride Injection · Injection · Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97)

Current · Reverified · updated 2026-11-03 · NDC 63323-496-97 · reason: Demand increase for the drug · availability: Unavailable

Check current status at FDA

Fresenius Kabi USA, LLC

Dextrose Monohydrate 10% Injection · Injection · Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74)

Current · Revised · updated 2026-11-03 · NDC 63323-824-74 · reason: Demand increase for the drug · availability: Limited Availability

Check current status at FDA

Fresenius Kabi USA, LLC

Morphine Sulfate Injection · Injection · Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01)

Current · Reverified · updated 2026-11-03 · NDC 63323-455-01 · reason: Demand increase for the drug · availability: Unavailable

Check current status at FDA

Fresenius Kabi USA, LLC

Dexamethasone Sodium Phosphate Injection · Injection · Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10)

Current · Reverified · updated 2026-11-03 · NDC 76045-0212-10 · reason: Demand increase for the drug · availability: Unavailable

Check current status at FDA

Fresenius Kabi USA, LLC

Dextrose Monohydrate 5% Injection · Injection · Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-464-50)

Current · Revised · updated 2026-11-03 · NDC 65219-464-50 · reason: Demand increase for the drug · availability: Limited Availability

Check current status at FDA

Fresenius Kabi USA, LLC

Remifentanil Hydrochloride Injection · Injection · Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)

Current · Revised · updated 2026-11-03 · NDC 63323-723-03 · reason: Delay in shipping of the drug · availability: Available

Check current status at FDA

Fresenius Kabi USA, LLC

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection · Injection · Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)

Current · Revised · updated 2026-11-03 · NDC 63323-481-57 · reason: Demand increase for the drug · availability: Unavailable

Check current status at FDA

Fresenius Kabi USA, LLC

Morphine Sulfate Injection · Injection · Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01)

Current · Revised · updated 2026-11-03 · NDC 63323-452-01 · reason: Other · availability: Unavailable

Check current status at FDA

Ask the same questions against your own records

Arca reads FDA's enforcement history the way this issue was written, and reads it against your deviations, CAPAs and submissions, so a failure mode you are investigating comes back with the precedent attached and cited to the record.

Our team comes from

  • OpenAI
  • Ramp
  • Apple
  • Legend Biotech
  • Microsoft
  • Merck